Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,971.00
Bid: 1,971.00
Ask: 1,972.00
Change: -29.00 (-1.45%)
Spread: 1.00 (0.051%)
Open: 2,008.00
High: 2,012.00
Low: 1,958.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Hikma in joint-venture to tap high-growth Ethiopian market

Wed, 18th Sep 2013 11:43

By Paul Sandle

LONDON, Sept 18 (Reuters) - Jordan's Hikma Pharmaceuticals has formed a joint venture with Sheikh Mohammed HusseinAl Amoudi's MIDROC Group to enter the Ethiopian healthcaremarket, where health spending is likely to more than double inthe next few years.

London-listed Hikma said the joint venture, HikmaCure, wouldcreate an Ethiopian operating company, build a localmanufacturing facility and would begin marketing anddistributing pharmaceutical products in Ethiopia.

"Ethiopia is still very underdeveloped in terms of thepharmaceutical market," Mazen Darwazah, executive vice chairmanand chief executive of Hikma's Middle East and North Africabusiness, said in an interview.

"It's a market that has huge potential for growth. We areexpecting an increase in expenditure on healthcare: today is$400 million but we are expecting it in the next couple of yearsto go up to $1 billion."

Ethiopia, Africa's second most populous nation, has seen adecade of double-digit growth, and it has leapfroggedneighbouring Kenya to become sub-Saharan Africa's fifth biggesteconomy.

The country's population of 91 million people is served byjust 5,000 doctors, compared with 40,000 doctors in Egypt for 85million people, Hikma said.

Hikma and MIDROC will provide up to $22.3 million each tothe joint venture, Hikma said.

Hikma manufactures and sells branded pharmaceuticals inMiddle Eastern and North African markets including Algeria,Saudi Arabia and Sudan. It also has a U.S. focused genericsbusiness and an injectables unit.

Jeddah-based MEDROC, which has operations in sectorsincluding petroleum, agriculture, engineering and construction,is a major investor in Ethiopia, where it has based its Africanoperations. The group's chairman, Sheikh Mohammed Al-Amoudi, isof Ethiopian-Yemeni heritage, according to his website, and heis the largest foreign investor in Ethiopia.

Analyst James Vane-Tempest at Jefferies said the jointventure was a positive for the company and it added furthercredibility to its expansion strategy.

"Ethiopia is one of the largest markets in the region and inour view offers strong long-term growth potential," he said.

Shares in the group were up 0.9 percent at 1,036 pence by1016 GMT.

More News
27 Aug 2021 12:32

Hikma, Bio-Thera enter exclusive agreement for monoclonal antibody

(Sharecast News) - Bio-Thera Solutions and Hikma Pharmaceuticals have entered into a commercialisation and license agreement to commercialise a monoclonal antibody used for the treatment of Crohn's disease.

Read more
20 Aug 2021 09:46

LONDON BROKER RATINGS: Peel Hunt ups InterContinental Hotels to Hold

LONDON BROKER RATINGS: Peel Hunt ups InterContinental Hotels to Hold

Read more
20 Aug 2021 08:10

LONDON BRIEFING: Softbank's Fortress doesn't give up on Morrisons

LONDON BRIEFING: Softbank's Fortress doesn't give up on Morrisons

Read more
17 Aug 2021 09:46

UPDATE 2-Energy, healthcare stocks lift FTSE 100; BHP Group shines

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* UK employment closer to pre-pandemic levels* BHP Group jumps on strong results* PLUS500 gains on robust revenue forecasts* FTSE 100 up 0.3%...

Read more
12 Aug 2021 16:04

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
6 Aug 2021 17:06

LONDON MARKET CLOSE: FTSE 100 boosted by strong US jobs report

LONDON MARKET CLOSE: FTSE 100 boosted by strong US jobs report

Read more
6 Aug 2021 12:07

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

Read more
6 Aug 2021 09:03

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

Read more
6 Aug 2021 08:40

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

Read more
6 Aug 2021 07:42

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

Read more
6 Aug 2021 07:22

Hikma lifts FY generics guidance as first-half profits, revenue jump

(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance for its generics arm and reported a rise in first-half profit and revenue as it hailed a strong performance in both the generics and branded segments, and resilience in the injectables business.

Read more
30 Jul 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
14 Jul 2021 19:38

IN BRIEF: Arecor ends first half of 2021 with solid cash position

IN BRIEF: Arecor ends first half of 2021 with solid cash position

Read more
13 Jul 2021 10:00

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

Read more
1 Jul 2021 09:51

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.